Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Southeast Asian ovalocytosis (SAO) is a rare hereditary red cell membrane defect characterized by the presence of oval-shaped erythrocytes and with most patients being asymptomatic or occasionally manifesting with mild symptoms such as pallor, jaundice, anemia and gallstones.
Features include: Elliptocytosis and Red blood cell destruction (hemolytic anemia).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 1 | Red blood cell destruction (hemolytic anemia) |
SLC4A1 function has not been fully characterized.
Southeast Asian ovalocytosis is associated with mutations in the SLC4A1 gene on chromosome 17.
Genetic testing for SLC4A1 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for southeast Asian ovalocytosis.
2 publications have been identified in PubMed for southeast Asian ovalocytosis. Kisho has analyzed 1 by research type. Research spans Other (100%).
Helmi MAM (2026). [PMID: 42136905](https://pubmed.ncbi.nlm.nih.gov/42136905/). *Mediterr J Hematol Infect Dis*. [Other]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 4:32 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center